1. China flexes: The world's second-largest economy grew 6.9% last year, beating analyst expectations.
China's performance was helped by government stimulus and an improving environment for global trade.
It's the first time since 2010 that China's official growth rate has bested the prior year. The economy grew 6.7% in 2016.
Chinese stocks gained Thursday, with Hong Kong's Hang Seng hitting a record high. The Shanghai Composite rose to its highest level in over two years.
2. U.S. government shutdown risk: House Republican leaders are moving toward a vote Thursday to avoid a government shutdown.
But it's unclear if GOP leaders have enough support to keep the government open.
If Congress doesn't send a bill to the president approving more money by midnight on Friday, most federal agencies will be forced to stop operations.
A shutdown could derail a major market rally.
The Dow soared by 323 points yesterday to close above 26,000 for the first time.
3. Earnings: Morgan Stanley will release earnings before the open, with American Express and IBM following after markets close.
Investors will be watching earning to see how companies assess new U.S. tax rules.
American companies with global operations are expected to pay hundreds of billions of dollars on the overseas profits they've amassed in recent decades.
But most companies say the tax changes are a good thing in the long run.
Apple said Wednesday it would make a $38 billion tax payment in relation to new tax rules.
4. Coming this week:
Thursday -- Morgan Stanley, IBM earnings
Friday -- January consumer sentiment report released by the University of Michigan
- China GDP; U.S. shutdown threat; IBM earnings
- Shutdown looms; IBM drops; Schlumberger earnings
- Dollar dissonance; U.S. GDP; Walmart's Kindle rival
- Retailers report; GDP updates; Stocks muddle along
- Shutdown continues; Netflix earnings; Pharma takeover
- China tariffs; Zuckerberg apology; Nike earnings
- Shutdown threat; Catalonia vote; Brexit bites
- IBM's sales grew for the first time in 5 years
- IBM and Microsoft battle over top workplace diversity exec
- Warren Buffett buys a drugmaker and dumps IBM